| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/23/2002 | US6423271 Multilayer lamination device, exterior support, fluid pumps |
| 07/23/2002 | CA2369183A1 Means and methods for treatment evaluation |
| 07/23/2002 | CA2303598C Tandem immuno-assay for cancer |
| 07/22/2002 | WO2002057760A1 Method of detecting substance inhibiting type iii secretion mechanism of bacterium and the function of secretory protein tbereof |
| 07/22/2002 | CA2369373A1 A method for detecting substances inhibiting the bacterial type iii secretion mechanism and function of secretory proteins thereof |
| 07/18/2002 | WO2002056057A2 Dotted micro-array data extraction method |
| 07/18/2002 | WO2002056030A2 Method and device for collecting and stabilizing a biological sample |
| 07/18/2002 | WO2002056027A2 Regulation of neutral development by daedalos |
| 07/18/2002 | WO2002056022A2 Diagnostics, drug screening and treatment for cancer |
| 07/18/2002 | WO2002056020A1 Complexes of solid with polymer for biological assay |
| 07/18/2002 | WO2002056015A1 Marker for inflammatory conditions |
| 07/18/2002 | WO2002056013A2 Oxazolidinone photoaffinity probes, uses and compounds |
| 07/18/2002 | WO2002056012A1 Fluorescent analysis element with the use of metallic nanowell and process for producing the same |
| 07/18/2002 | WO2002055995A2 Method and system for modeling cellular metabolism |
| 07/18/2002 | WO2002055988A2 Novel methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators |
| 07/18/2002 | WO2002055985A2 Methods and reagents for identifying rare fetal cells in the material circulation |
| 07/18/2002 | WO2002055742A2 Rapid method for screening compounds for in vivo activity |
| 07/18/2002 | WO2002055741A2 Method for detection of drug-induced mutations in the hiv reverse transcriptase gene |
| 07/18/2002 | WO2002055740A2 Method for detecting disease associated mutations by means of primer extension |
| 07/18/2002 | WO2002055739A2 Nucleic acid extraction solution and use thereof |
| 07/18/2002 | WO2002055737A1 Compositions and methods for dna purification from whole blood |
| 07/18/2002 | WO2002055736A2 Antisense imaging of gene expression of the brain in vivo |
| 07/18/2002 | WO2002055735A2 Compositions and methods relating to prostate specific genes and proteins |
| 07/18/2002 | WO2002055734A1 A method and test kit for quantitative determination of variations in polynucleotide amounts in cell or tissue samples |
| 07/18/2002 | WO2002055732A2 Mdt(a), a new efflux protein conferring multiple antibiotic resistance, and uses therefor |
| 07/18/2002 | WO2002055730A2 Hygiene monitoring |
| 07/18/2002 | WO2002055729A1 Method and device for detecting microorganisms on surfaces |
| 07/18/2002 | WO2002055725A2 Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production |
| 07/18/2002 | WO2002055721A2 Modular transfection systems based on nucleoprotein filaments |
| 07/18/2002 | WO2002055720A2 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 07/18/2002 | WO2002055718A2 Assembly and screening of highly complex and fully human antibody repertoire in yeast |
| 07/18/2002 | WO2002055710A2 Regulation of human purple acid phosphatase |
| 07/18/2002 | WO2002055706A2 Asip-related proteins |
| 07/18/2002 | WO2002055705A2 Proteins and nucleic acids encoding same |
| 07/18/2002 | WO2002055703A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/18/2002 | WO2002055700A2 Human genes and gene expression products isolated from human prostate |
| 07/18/2002 | WO2002055698A2 Transcriptional mediators of blood vessel development and endothelial differentiation |
| 07/18/2002 | WO2002055695A1 Human glioma antigen and process for preparing the same |
| 07/18/2002 | WO2002055691A1 Gene encoding aip-1/flash promoter and use thereof |
| 07/18/2002 | WO2002055680A2 Morphometric tissue or cell preparation |
| 07/18/2002 | WO2002055678A1 Extramedullary adipose tissue cells and use thereof for regenerating hematopoietic and muscular tissues |
| 07/18/2002 | WO2002055669A2 Regulation of target protein activity through modified proteins |
| 07/18/2002 | WO2002055665A2 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders |
| 07/18/2002 | WO2002055664A2 Modulating insulin receptor signaling |
| 07/18/2002 | WO2002055663A2 Srebp pathway modulation through targeting hisrs |
| 07/18/2002 | WO2002055655A2 Metylococcus capsulatus genes and dna array for the determination of gene expression in metylococcus capsulatus |
| 07/18/2002 | WO2002055555A2 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 07/18/2002 | WO2002055536A2 Regulation of target protein activity through modifier proteins |
| 07/18/2002 | WO2002055534A2 Haplotypes of the f2rli gene |
| 07/18/2002 | WO2002055533A2 Methods of using imxp-888 and imxp-888 antagonists |
| 07/18/2002 | WO2002055099A2 Modulation of pericyte proliferation using bpi protein products or bpi inhibitors |
| 07/18/2002 | WO2002055017A2 Method of treating autoimmune diseases |
| 07/18/2002 | WO2002055015A2 Rapid antibiotic susceptibility test |
| 07/18/2002 | WO2002054865A1 Method of selecting antimicrobial agent and method of using the same |
| 07/18/2002 | WO2002054856A1 Chemical inhibitors of mismatch repair |
| 07/18/2002 | WO2002044422A8 Method for ultra-high resolution mapping of genes and determination of genetic networks among genes underlying phenotypic traits |
| 07/18/2002 | WO2002044198A3 Haplotypes of the slc1a4 gene |
| 07/18/2002 | WO2002033129A3 Nucleic acid amplification controls |
| 07/18/2002 | WO2002031501B1 Methods for synthesizing reporter labeled beads |
| 07/18/2002 | WO2002029402A3 System for electrophysiological measurements |
| 07/18/2002 | WO2002029088A3 Highly expressible genes |
| 07/18/2002 | WO2002029003A3 Massive parallel method for decoding dna and rna |
| 07/18/2002 | WO2002028414B1 Compositions and methods for wt1 specific immunotherapy |
| 07/18/2002 | WO2002027014A3 Detection of fecal contamination |
| 07/18/2002 | WO2002026771A3 Haplotypes of the scya7 gene |
| 07/18/2002 | WO2002026116A9 Repair and regeneration of cartilage, collagen and bone remodeling |
| 07/18/2002 | WO2002022855A3 Test-strips with positively charged membranes for tetrazolium based assays |
| 07/18/2002 | WO2002022078A3 Enzyme method for detecting sphingosine-1-phosphate (s1p) |
| 07/18/2002 | WO2002021098B1 A method for identifying polymorphisms |
| 07/18/2002 | WO2002018539A3 Method for assaying the activity of lysosomal enzymes |
| 07/18/2002 | WO2002014533A3 Creatinine sensor calibration |
| 07/18/2002 | WO2002006834A9 Nested sorting and high throughput screening |
| 07/18/2002 | WO2002006517A9 High-throughput methods for generating and screening compounds that affect cell viability |
| 07/18/2002 | WO2002006311A3 Olfactory g-protein coupled receptor |
| 07/18/2002 | WO2002006242A3 5-substituted 2-aryl-4-pyrimidinones |
| 07/18/2002 | WO2002002822A3 Method of managing and marketing livestock based on genetic profiles |
| 07/18/2002 | WO2002002795A3 Multiplex sequencing method |
| 07/18/2002 | WO2002002633A3 Transporters and ion channels |
| 07/18/2002 | WO2002000927A3 Diagnosis of diseases associated with development by means of assessing their methylation status |
| 07/18/2002 | WO2002000926A8 Diagnosis of diseases associated with signal transduction |
| 07/18/2002 | WO2001096862A3 Method for increasing luminescence assay sensitivity |
| 07/18/2002 | WO2001094951A3 Inhibitors of c-reactive protein induced inflammation |
| 07/18/2002 | WO2001094391A3 Intracellular signaling proteins |
| 07/18/2002 | WO2001090328A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/18/2002 | WO2001090116A3 Haplotypes of the apobec2 gene |
| 07/18/2002 | WO2001087980A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 07/18/2002 | WO2001087908A3 Haplotypes of the ccr3 gene |
| 07/18/2002 | WO2001084149A3 Diagnostics and therapeutics for macular degeneration-related disorders |
| 07/18/2002 | WO2001083749A3 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners |
| 07/18/2002 | WO2001081590A3 Protein phosphatases |
| 07/18/2002 | WO2001081586A3 21657, a human short-chain dehydrogenase and uses thereof |
| 07/18/2002 | WO2001081547A3 Identification, cloning and characterization of a novel pc-1 gene differentially expressed in prostate cells and tissues |
| 07/18/2002 | WO2001081408A3 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 07/18/2002 | WO2001079468A3 Drug metabolizing enzymes |
| 07/18/2002 | WO2001079282A3 Molecules associated with human reproduction |
| 07/18/2002 | WO2001073117A9 Use of particles which have signal-emitting characteristics and at least one group with an affinity for marked nucleic acids |
| 07/18/2002 | WO2001072822A3 Genes involved in intestinal inflammatory diseases and use thereof |
| 07/18/2002 | WO2001071041A3 Microarray-based analysis of polynucleotide sequence variations |
| 07/18/2002 | WO2001068705A3 Il-17 receptor like molecules and uses thereof |
| 07/18/2002 | WO2001066747A3 Proteins named fctrx and nucleic acids encoding same |